Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hayden

Showing results (361-370 of 391) with videos related to

Pageof 40
Sort By:
The New England Journal of Medicine|February 9, 2017
Middle East Respiratory SyndromeYaseen M Arabi, Hanan H Balkhy, Frederick G Hayden, et al.
Neuron|December 22, 2015
Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with MouseYe Zhang, Steven A Sloan, Laura E Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2019
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal InfluenzaaTimothy M Uyeki, Henry H Bernstein, John S Bradley, et al.
Trials|May 26, 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trialYeming Wang, Fei Zhou, Dingyu Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2018
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal InfluenzaaTimothy M Uyeki, Henry H Bernstein, John S Bradley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infectionsN Lee, D S C Hui, Z Zuo, et al.
Springerplus|December 1, 2015
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolYaseen Arabi, Hanan Balkhy, Ali H Hajeer, et al.
The Lancet. Infectious Diseases|December 22, 2006
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virusHolger J Schünemann, Suzanne R Hill, Meetali Kakad, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Clinical and Economic Impact of COVID-19 on Plantation Workers: Preliminary Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) StudyDaniel Olson, Diva M Calvimontes, Molly M Lamb, et al.
Ebiomedicine|November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenzaYeming Wang, Wu Zhong, Alex Salam, et al.
Pageof 40

Showing results (361-370 of 391) with videos related to

Sort By:
Pageof 40
The New England Journal of Medicine|February 9, 2017
Middle East Respiratory SyndromeYaseen M Arabi, Hanan H Balkhy, Frederick G Hayden, et al.
Neuron|December 22, 2015
Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with MouseYe Zhang, Steven A Sloan, Laura E Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2019
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal InfluenzaaTimothy M Uyeki, Henry H Bernstein, John S Bradley, et al.
Trials|May 26, 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trialYeming Wang, Fei Zhou, Dingyu Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2018
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal InfluenzaaTimothy M Uyeki, Henry H Bernstein, John S Bradley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infectionsN Lee, D S C Hui, Z Zuo, et al.
Springerplus|December 1, 2015
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolYaseen Arabi, Hanan Balkhy, Ali H Hajeer, et al.
The Lancet. Infectious Diseases|December 22, 2006
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virusHolger J Schünemann, Suzanne R Hill, Meetali Kakad, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Clinical and Economic Impact of COVID-19 on Plantation Workers: Preliminary Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) StudyDaniel Olson, Diva M Calvimontes, Molly M Lamb, et al.
Ebiomedicine|November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenzaYeming Wang, Wu Zhong, Alex Salam, et al.
Pageof 40